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Article Information  ABSTRACT 
Received: 11th March 2017  The aim of present study was to develop and evaluate time controlled release tablet of 
Ketoprofen intended for rheumatoid arthritis. The cardinal sign of rheumatoid arthritis are 
stiffness, swelling and pain of one or more joints of the body characteristically most severe in 
the morning. Rheumatoid arthritis shows a significant circadian variation in its symptoms. Time 
controlled release tablet delivers the drug at definite time or in controlled rate. It consist of core 
tablet coated with two layers, the inner swelling layer and outer rupturable. Before compression 
of core tablet, drug- excipients compatibility study and precompression parameters were 
investigated. Core tablet was prepared by direct compression method. The core tablets are 
coated with crosscarmellose sodium as inner swelling layer with different coating level. The 
prepared tablet again evaluated and coated with rupturable layer of ethylcellulose. The free film 
of ethylcellulose was evaluated for various parameters. The effect of microcrystalline cellulose 
and coating level of rupturable layer and swellable layer on lag time were investigated. The 
results shows as the amount of microcrystalline cellulose increase in core tablet the lag time 
decreases. The lag time increases with increase in coating level of swelling layer and rupturable 
layer. The water uptake study shows that higher ethylcellulose levels retards the water uptake 
and prolongs the lag time.  
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INTRODUCTION 
The impetus for the development of newer drug delivery 
system, apart from therapeutic efficiency, is the cost. The 
development cost of a new drug may require about $250 
millions (Rs. 900 cores) and takes about 12 - 15 years to reach 
the market. An existing drug molecule can be developed as a 
newer drug delivery system in half the time, with 20% cost of 
new drug discovery [1]. Chronobiology is the science 
concerned with the biological mechanism of the diseases 
according to a time structure and chronopharmacology, is the 
science concerned with variations in the pharmacological 
actions of various drugs over a period of time and base on this, 
chronotherapeutics is the discipline concerned with the delivery 
of drugs according to inherent activities of a disease over a 
certain period of time [2] 
 
The goal of chronotherapeutics is to match the timing of 
treatment with the intrinsic timing of illness. The best therapy 
is that when the right amount of the drug is delivered to the 
correct target organ at the most appropriate time [3]. 
Chronotherapy provides ways of increasing the effectiveness 
and safety of arthritis medications. The chronotherapy of 
arthritic disease involves determining the best time to take 
NSAIDs or other types of medicines to improve their desired 
effects and avoid or minimize unwanted ones. At present, more 
than 50 different NSAIDs are available on the market and no 
one is ideal in controlling or modifying the signs and symptoms 
of inflammation hence Ketoprofen is selected in this work. The 
time controlled release tablet of ketoprofen intended to 
approximate the chronobiology of rheumatoid arthritis. It is a 
chronopharmaceutical approach for the better treatment of 
arthritic pain. 
 
MATERIALS AND METHODS 
Ketoprofen used as an active ingredient gifted by Zim Lab. 
India. Microcrystalline cellulose gifted Avicel® PH 102, FMC 
USA, Spray dried lactose gifted by Flowlac® 100 Germany 
,Magnesium stearate and talc gifted by Loba chem. India was 
used as ingredients of core tablet. Croscarmellose sodium 
gifted by Ac-Di-sol®, FMC was used as swelling agent and 
PVP gifted by Kollidone® 90F BASF, Germany as binder. The 
ethyl cellulose (Ethocel® standard 4) gifted by Colorcon Asia 
Ltd. India was used for rupturable coating and plasticized with 
Dibutylphthalate Ranchem Ltd. India). All other reagents were 
of analytical grade. 
Preparation and Optimization of Core Tablet 
Drug-Excipient compatibility study:  
The samples of drug and excipients were evaluated for drug-
excipients compatibility study by differential scanning 
colorimeter (DSC) using Perkin Elmer DSC model-7. The 
instrument calibrated with indium and zinc prior to analyzing 
the samples under nitrogen. Sample (1-2mg) was accurately 
weighed and sealed hermetically in flat bottom open aluminum 
cells at a scanning rate of 5˚C/min conducted over a 
temperature range of 30- 250˚C. The samples were heated in 
sealed aluminum pans under nitrogen flows (50 ml/min) [4] 
and Fourier transformed infrared spectroscopy (FT-IR) using 
KBr disc method. Each sample was gently triturated with KBr 
powder in a weight ratio of 1: 100 and pressed using a 
hydrostatic press at a pressure of 10 tons for 5 min. The disc 
was placed in the sample holder and scanned from 4600 to 400 
cm-1 at a resolution of 1 cm-1 at zero time [5] 
 
Micromeritic properties of core tablet powder blend and 
Preparation of core tablet:  
Before compression, blends were evaluated for their 
characteristic parameters such as bulk density, tapped density, 
Hausner’s ratio, compressibility index using a digital tap 
density apparatus (Electrolab Ltd, India) [6]. Core tablets were 
prepared by direct compression method as per the composition 
Table 1. All the excipients first pass through the sieve no. 100. 
Then Ketoprofen, microcrystalline cellulose, spray dried 
lactose were simply mixed with each other in a poly bag for 30 
minutes for uniform mixing followed by the addition of 
magnesium stearate and talc. Core tablets were compressed by 
pilot press tablet machine (Chamunda Pharma Machinery Pvt. 
Ltd., India) with diameter, 7 mm; biconvex; average tablet 
Weight 150 mg [7] 
 
Table 1 - Different composition of core tablet 
Ingredients C1 
(mg) 
(100:0) 
C2 
(mg) 
(70:30) 
C3 
(mg) 
(50:50) 
C4 
(mg) 
(30:70) 
C5 
(mg) 
(0:100) 
Ketoprofen 50 50    50 50 50 
Lactose* 98.5 68.95   49.25 29.55 ---- 
MCC* --- 29.55   49.25 68.95 98.5 
Magnesium 
stearate 
0.75 0.75 0.75 0.75 0.75 
Talc 0.75 0.75 0.75 0.75 0.75 
*Spray dried Lactose & MCC – Microcrystalline Cellulose 
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Evaluation of core tablet 
Core tablet evaluated as per the official tests for tablets 
mentioned in the pharmacopoeias such as weight variation, as 
per I.P. Hardness by using Monasanto Hardness tester, 
thickness by using Vernier calipers and expressed in mm, 
friability using Roche friabilator. The disintegration time was 
determined using USP tablet disintegration test apparatus (ED 
2L, Electrolab, India. The dissolution study was carried out 
using USP type II paddle apparatus in 6.8 p H phosphate buffer 
(900 ml) at 37ºC±0.5ºC at speed 50±5 rpm. At specified time 
intervals, 5 ml samples were collected and immediately 
replaced with an equal volume of fresh medium. Samples were 
suitably diluted & analyzed by using UV spectrophotometer [8] 
 
Coating of core tablet with swellable layer of 
croscarmellose sodium 
The croscarmellose sodium was dispersed in alcoholic solution 
of polyvinyl pyrrolidone (90F kollidone®) at a ratio of 6:1 
w/w. 0.667g Kollidon 90F was dissolved in the 100 ml 96% 
v/v ethanol by stirring, using a magnetic stirrer till clear 
solution was obtained. The croscarmellose sodium was passed 
through the sieved no. 150 and 4g of Crosscarmellose (Ac-Di-
Sol) were dispersed into the Kollidon 90F solution and agitated 
for at least 30 minutes to obtain a homogeneous dispersion. 
The core tablet was coated with coating dispersion to obtained 
coating level of 10 mg/ cm2, 20 mg/cm2 and 30 mg/cm2.The 
coating condition were spray rate of 1ml/min., pan speed at 
30rpm and inlet hot air temperature of 40˚C. The coated tablet 
further dried in coating pan for 10 min with hot air after 
completion of coating process. The tablets were placed in an 
oven at 40˚C for 2 hours to remove residual solvent [9]. The 
swellable layer coated tablet again evaluated as per the official 
tests for tablets. 
 
Coating of swellable layer core tablet with rupturable layer 
of Ethylcellulose 
Preparation and evaluation of free film of Ethylcellulose:  
Free film of ethyl cellulose was prepared by mercury substrate 
technique. The solution of ethyl cellulose was prepared in 
ethanol by stirring for 30 min. then solution was poured in Petri 
dish containing mercury and solvent was allowed to evaporate 
in an oven at 60 ˚c to 70˚c [10]. The thickness of film was 
determined using Digital Verniar Caliber instrument at a 
different point throughout the film and the mean of five 
measurements were recorded. The diffusion study of film was 
determined by using Keshary-Chein diffusion cell [11]. 
Moisture Absorption study was carried out in glass desiccators 
maintained at controlled relative humidity conditions by use of 
different saturated salt solution such as potassium acetate, 
potassium carbonate, sodium chloride and potassium nitrate. 
After equilibrating the desiccators with appropriate 
concentration of saturated salt solution for three days, 
accurately weighed film placed in Petri dish were kept in the 
desiccators undisturbed for 14 days [12]. The difference in 
weight gives the amount of moisture observed at various 
relative humidity. 
 
Water vapor transmission rate study (WVTR): The films were 
cut to a suitable size and thickness of the dry films were 
determined by Digital Verniar Caliber instrument and were 
mounted on assembled transmission cell (vials).These vials 
contains a saturated salt solution of sodium chloride, to provide 
the relative humidity (RH) condition of 75% and the charged 
vials were weighed and placed in pre equilibrated desiccators 
maintained at 0% RH, containing fused calcium chloride. The 
vials were reweighed in the same manner at 24 h interval for 72 
h. The amount of water transmitted through the film was given 
by the loss of weight of the vials [13]. The rate of water vapor 
transmission was calculated using the following Utsumi's WVT 
equation: 𝑄 =
𝑊𝐿
𝑆
 
 Where W = Gm of water transmitted per 24 hours, L = film 
thickness in cm, S =Surface area in sq. cm, Q = water vapor 
transmission in g .cm thickness /cm2 areas 24 hours. 
 
To determine mechanical properties of film, a tensile test was 
performed on Instron (Model - 4467, Instron crop, Carton, MA) 
instrument based on ASTM standard test principle. The gauge 
length was kept at 500 mm and crosshead speed was 1.0000 
mm / min and the test was performed at 50% RH at room 
temperature. The mechanical properties viz tensile strength, 
percentage elongation and modulus of elasticity were 
automatically computed by the instrument. Each experiment 
was repeated at least three times [14] 
 
Coating of swellable layer coated tablet of Ketoprofen with 
rupturable layer 
Swellable layer coated tablets were then coated with an 
ethanolic solution of ethyl cellulose, using dibutyl phthalate as 
a plasticizer. The coating solution was prepared by dissolving 
3.5 g ethyl cellulose in 100 ml of 96% v/v ethanol (3.5% w/w 
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solution) and stirred on a magnetic stirrer to obtain a clear 
solution. The plasticizer (5% w/w based on polymer solids) 
was added into the polymer solution i.e. 0.176 ml and the 
solution was further agitated for at least 30 min before coating 
to obtain a homogeneous solution. The homogeneous 
dispersion was gently stirred throughout the coating process. 
The polymer solution was sprayed onto the tablets in a 
conventional coating pan (2.5 inch) and other specification 
regarding coating conditions were same as described in 2.2.6. 
The coated tablets were further dried in the coating pan for 15 
min at 40 C̊ after the coating process was finished and then 
placed in the oven at 40 C̊ for 2 h to remove the residual 
solvent [15]. The coated tablets were equilibrated at room 
temperature overnight and stored in a closed container before 
further experiments. 
 
Evaluation of Time Controlled Release Tablet 
Scanning Electron Microscopy: The scanning of morphology 
of a cross-section of the time controlled release tablet of 
Ketoprofen was carried out by using Scanning Electron 
Microscopy (JSM-6360).The sample of time controlled release 
tablet was mounted on stage and coated with gold under 
vacuum [16] 
 
Rupture test: The rupture test was carried out by using 900ml 
of phosphate buffer pH 6.8 in the dissolution apparatus USP 
TYPE-II at 50 rpm and temperature condition 37±0.5˚C.The 
sequence of rupturing of Time controlled release tablet was 
observed and photographs taken using a digital camera (Sony 
Ericsson) [17] 
 
Water uptake Study: The water uptake study of time controlled 
release tablet of Ketoprofen was done using screw-caped 
container containing 100ml of phosphate buffer pH 6.8 .In this 
container tablet was added and placed in horizontal water bath 
shaker.(Remi equipments Pvt Ltd.) and temperature was 
maintained at 37±0.5˚C.The tablet was withdrawn at 
predetermined time intervals from dissolution media and 
weight of tablet was taken after removing the surface water by 
carefully blotting the tablet with tissue paper and tablet was 
again added to the medium. The same procedure was repeated 
until the rupturing of coat occurs [18] 
 
Swelling Index: Swelling index was determined by weighing 
four tablets separately (m1) and each weighed tablet was placed 
into a beaker containing 6ml of phosphate buffer pH 6.8 at 
37±0.5˚c. The tablets were removed from beaker at specified 
time interval and from the surface of tablet excess water was 
removed using tissue paper. Each swollen tablet was weighed 
(m2) and swelling index was calculated [19] 
 
In – Vitro Dissolution studies: In vitro dissolution studies of 
time Controlled release tablets of Ketoprofen were performed 
using USP paddle dissolution apparatus. The other conditions 
which were maintained throughout the test are paddle speed of 
50 rpm at 37˚c using 900ml of Ph 6.8 phosphate buffer. Sample 
of 10 ml was withdrawn at regular interval of 60 minutes by 
using 10 ml of calibrated pipette upto 6hrs and then regular 
interval of 15min. The volume withdrawn was replaced by 
fresh volume of dissolution medium. The sample was analyzed 
spectrophotometrically at 258 nm. The amount of drug release 
was determined using calibration curve (PCP-Disso software) 
 
RESULTS AND DISCUSSION  
The DSC thermograms Figure 1, shows the endothermic peaks 
as given in the literature.  
  
Figure 1: DSC Thermograms of Ketoprofen, physical mixture of core tablet (drug with excipient) and physical mixture of 
optimized time controlled release tablet (core tablet with coating material) 
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Figure 2. Infra red (FT-IR) spectrum of Ketoprofen, physical mixture of core tablet (drug with excipients and physical mixture of 
optimized time controlled release tablet (core tablet with coating material) 
 
The DSC thermograms of samples (pure drug, core tablet 
mixture and physical mixture core tablet with coating material) 
show the endothermic peaks as given in literature. It shows 
there was no considerable change in the endotherm values of 
Ketoprofen when mixed with excipients which shows no 
interaction between drug, polymer and excipients [20]. FT-IR 
spectrum of sample was shown in Figure 2 shows the entire 
characteristic peak. From the result of FT-IR spectra of pure 
drug, core tablet mixture and physical mixture core tablet with 
coating material it was observed that there was no interaction 
between drug and excipient. All the characteristic absorption 
peaks of ketoprofen at 3020 cm -1 (C–H stretching of  aromatic 
ring), 2970 cm-1 (C–H stretching of CH3 group), 1695 cm
-1 (C-
O stretching of acid), 1655 cm-1 (C-O stretching of ketone), 
1595 cm-1 (C-C stretching of aromatic  ring), 860 cm-1 (C–H 
deformation of aromatic ring) were observed [21] 
 
Micromeritic properties of core tablet powder blend 
The Micromeritic properties or precompression parameter such 
as angle of repose, bulk  density, tapped density, Hausner’s 
ratio, Carr’s index of core tablet powder was found to be 
satisfactory and it indicates that powder blend has good flow 
property with good compressibility and suitable for direct 
compression method [22]. The core tablets were subjected to 
various evaluation tests such as thickness, hardness, weight 
variation, friability, drug content and disintegration test [23].  
The results of the various tests were mentioned in Table 3.  
The thickness, hardness, drug content, disintegration time, 
Weight variation and Friability of core tablet of ketoprofen was 
also found to be within range. The result of dissolution studies 
of formulation C1, C2, C3, C4, C5 composed of varying 
concentration of spray dried lactose and microcrystalline 
cellulose are shown in Figure 3.  
 
 Figure 3: In-vitro drug release profile of formulation C1 to C5 
 
The dissolution study of core tablet was carried out and it was 
observed that the core tablet without microcrystalline cellulose 
(spray dried lactose100: 0 Microcrystalline cellulose, 100:0 
w/w) showed the steepest slope. As the concentration of 
microcrystalline cellulose increases in the core it lowers the 
release rate of drug. According to this result, core tablets 
consisting of spray dried lactose and microcrystalline cellulose 
with a 70:30 w/w ratio was used for further studies [24] 
 
Table 2: Flow properties of core tablet composition (Mean ± SD) 
Test C1 C2 C3 C4 C5 
Angle of repose 33.09 ±0.16 30.1967±0.14 30.0067 ±0.22 29.4767 ±0.23 28.89 ±0.17 
Bulk density 0.5979±0.07 0.5898±0.06 0.5958 ±0.0843 0.6026 ±0.047 0.6168 ±0.058 
Tapped density 0.7219±0.04 0.7198±0.03 0.7133 ±0.0467 0.7199 ±0.03 0.7264 ±0.049 
Carr's index 17.17 16.53 16.47 16.29 15.08 
Hausner's ratio 1.22 1.22 1.19 1.19 1.17 
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Table 3: Different evaluation parameters of core tablets  
S. No Test C1 C2 C3 C4 C5 
1. Thickness (mm) 3.32±0.12 3.36± 0.02 3.27±0.08 3.32±0.05 3.30±0.07 
2. Hardness (kg/cm2) 3.45 ±0.11 3.52 ± 0.04 3.60 ±0.95 3.88±0.51 4.23 ± 0.05 
3. Friability 0.84±0.4 0.89±0.2 0.87±0.3 0.80±0.8 0.86±0.6 
4. Drug content (%) 99.13 ±0.59 98.43±0.39 98.78 ±0.21 99.93±0.4 99.53 ± 0.1 
5. Weight Variation(mg) 150±5.5 150±6.2 150±4.1 150±7.2 150±3.8 
6. Disintegration (min) 11.8 ± 0.21 6.6 ± 0.32 5.4 ± 0.13 4.9 ± 0.16 4.4 ± 0.12 
 
Table 4: Different evaluation parameters of swellable layer coated core tablets of Ketoprofen 
S. No. Test S-1(C2) (10mg/cm2) S-2(C2) (20mg/cm2) S-3(C2) (30mg/cm2) 
1. Thickness(mm) 4.09 ± 0.12 4.08 ± 0.02 4.09± 0.08 
2. Hardness(kg/cm2) 3.73 ± 0.15 4.73± 0.21 5.70 ± 0.95 
3. Friability 0.01±0.4 0.02±0.2 0.01±0.3 
4. Drug content (%) 99.13 ±0.59 98.43±0.39 98.78 ± 0.21 
5. Weight Variation(mg) 170±05 190±06 210±04 
6. Disintegration time(sec) 44±0.1 38±23 26±12 
 
The core tablets coated with swellable layer were subjected to 
various evaluation test and the results of the various tests were 
mentioned in Table 4. The hardness and thickness of core tablet 
coated with swellable layer of Ketoprofen was found to be high 
as compared to core tablet. The higher hardness might retard 
the water penetration through this layer and affect the drug 
release [25]. The core tablets coated with swellable layer were 
subjected to various evaluation test and the results of the 
various tests were mentioned in Table 4. The hardness and 
thickness of core tablet coated with swellable layer of 
Ketoprofen was found to be high as compared to core tablet. 
The higher hardness might retard the water penetration through 
this layer and affect the drug release [25]. The result of 
dissolution studies of formulation S1, S2, S3 coated with 
varying coating level (10mg/cm2, 20mg/cm2, 30mg/cm2) are 
shown in Figure 4 and  it was found that as the coating level of 
swellable layer increases the rate of drug release.  
 Figure 4 In-vitro drug release profile of formulation S1 (C2) to 
S3 (C2) 
The thickness of prepared ethylcellulose film was shown in 
Table 5. The thickness of film strongly affects the drug 
permeability of the film. The increase in the film  thickness 
decreases the permeation rate [26] 
Table 5: Thickness of ethyl cellulose film 
S. 
No. 
Polymer concentration of ethyl 
cellulose film (%) 
Thickness (mm) 
1. 1.5 0.05 
2. 2.5 0.07 
3. 3.5 0.09 
4. 4.5 0.10 
 
The drug diffusion of prepared ethyl cellulose film was shown 
in Table 6. From the diffusion study it was found that as the 
concentration of polymeric film increases the thickness of the 
film. As the thickness, of the film increases the diffusion rate 
decreases. The ethyl cellulose film, having a thickness of 0.09 
mm was selected for further study [27]. The percent moisture 
absorption test was carried out to check the physical stability 
and integrity of the films at high humid conditions.  
 
Moisture Absorption capacity of the film increases with an 
increase in humidity. Moisture will exert a temporal effect on 
the properties of polymeric film [28]. The Water vapor 
transmission rate of ethyl cellulose film was determined and 
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water vapor transmission rate of prepared ethyl cellulose film 
shown in Table 8. 
 
Table 6: Diffusion of ethyl cellulose film 
Polymer concentration of 
ethyl cellulose film (%) 
Thickness 
(mm) 
Time % Release 
1.5 0.05 15 
30 
45 
60 
45.44  
53.28  
63.92  
68.36 
2.5 
 
0.07 15 
30 
45 
60 
43.71  
45.23  
50.39  
52.92 
3.5 
 
0.09 15 
30 
45 
60 
38.79  
41.23  
29.66 
49.23  
4.5 
 
0.10 15 
30 
45 
60 
28.87  
29.24  
32.12  
36.04  
 
Table 7: Moisture absorption capacity of prepared ethyl 
cellulose film 
Film Percent moisture absorption at 
percent relative humidity 
23% 43% 75% 93% 
Ethyl cellulose (3.5%) ----- 1.65 3.07 3.57 
 
Table 8: Water vapor transmission rate of prepared ethyl 
cellulose film 
Film Area 
(cm2) 
Thickness 
(cm) 
WVTR X 10-4 (gm-
cm/cm2) 
24 h 48 h   72 h 
Ethyl 
cellulose3.5% 
1.24 0.09 1.37 ± 
0.14 
1.40 ± 
0.20 
1.48 ± 
0.15 
 
There was no significant difference in the permeability of 
ethylcellulose films plasticized with dibuylphthalate. Therefore 
the ethylcellulose film was suitable as a coating agent. It also 
offers good protection to water sensitive drugs. In 
pharmaceutical coating, these films can provide protection 
from atmospheric moisture [29].  
Mechanical properties of prepared ethyl cellulose film are 
shown in Table 9. 
Table 9. Mechanical properties of prepared ethylcellulose film 
 Film Tensile 
Strength 
(MPa) 
Percent 
elongation 
Modulus 
of 
Elasticity 
(MPa) 
Tensile 
Strength/ 
Modulus 
of 
elasticity 
(MPa) 
Ethyl 
cellulose 
(3.5%) 
2.17 ± 
0.22 
4.15 ± 3.0 140 ± 14 0.0156 
 
The mechanical properties of dry film of ethylcellulose show 
moderate tensile strength, high % elongation, low modulus of 
elasticity and low tensile strength to elastic modulus ratio. 
Therefore the prepared films were mechanically weak, brittle 
and easily ruptured on exposure to dissolution medium also due 
to internal pressure developed within the tablet core. 
 Dibutyl phthalate increases the % elongation of the ethyl 
cellulose film. The plasticizers with larger alkyl substituent 
produced tougher ethyl cellulose films. This phenomenon was 
due to higher hydrophobicity of the plasticizers, which was 
more compatible with water-insoluble ethyl cellulose. The 
dibutyl phthalate plasticized films were smoother and has 
homogenous surface. 
 The Surface morphology of prepared ethylcellulose film 
(3.5%) was examined using by scanning Electron Microscopy. 
The surface morphology of the film was shown in Figure 5.  
 
Figure 5. SEM scanned image of ethylcellulose film 
  
Evaluation of time controlled release tablet  
The time controlled release table (core tablets coated with 
swellable layer and further with ethylcellulose) were subjected 
to various evaluation tests such as rupture test, water uptake 
study, Swelling index, Scanning electron microscopy and 
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dissolution study. The thickness, hardness, weight variation, 
friability, drug content and disintegration test of time controlled 
release tablet of ketoprofen was also evaluated The results of 
the various tests were mentioned in Table 10. 
Table 10.Different evaluation parameters of time controlled release tablets of ketoprofen 
Sr. 
No. 
Batch No. 
Thickness 
(mm) 
Hardness 
(kg/cm2) 
Friability Drug content (%) 
Weight Variation 
(mg) 
1. TC1(S1C2) 4.12 ± 0.12 4.2 ± 0.11 0.01±0.11 99.18± 0.72 175±4.2 
2. TC2(S1C2) 4.11±0.3 4.3 ±0.11 0.03±0.12 99.81± 1.07 177±3.8 
3. TC3(S1C2) 4.13±0.5 4.2 ±0.10 0.01±0.09 99.54 ±0.50 179±3.5 
4. TC4(S2C2) 4.33±0.1 4.5 ±0.12 0.00±0.07 98.12±0.73 195±2.4 
5. TC5(S2C2) 4.40±0.4 4.6 ± 0.18 0.02±0.07 99.30 ± 0.87 197±2.6 
6. TC6(S2C2) 4.41±0.3 4.5 ±0.15 0.02±0.05 99.23 ± 0.90 199±2.5 
7. TC7(S3C2) 4.62±0.1 4.7 ± 0.21 0.01±0.08 99.50 ± 0.77 216±2.8 
8. TC8(S3C2) 4.66±0.4 4.8 ± 0.15 0.03±0.13 99.96 ± 0.27 218±3.1 
9. TC9(S3C2) 4.71±0.5 4.7± 0.15 0.01±0.12 99.56±0.76 220±2.2 
 
Time controlled release tablet of ketoprofen passes all the 
evaluation parameters of tablet. The thickness and hardness of 
the tablet increased with an increase in coating level of 
ethylcellulose rupturable layer of 2.5mg/cm2, 3.5mg/cm2, 
4.5mg/cm.2 
 
Lag time determination: To optimized the exact composition 
of time controlled release tablet, selected batches of core tablets 
were coated with 10 mg/cm2, 20 mg/cm2, 30 mg/cm2 of Ac-Di-
Sol layer and the lag time was determined as per procedure 
given in the rupture test 
 
Figure 6. Lag time of different Time controlled release tablets 
The lag time was determined during rupture test and found that 
all 9 batches (TC1-TC9) show an increase in the lag time with 
an increase in the coating level. The increase in coating level 
directly increases the coating thickness so the lag time too. The 
aim of the study was to develop a tablet which will be protected 
from gastric environment and will release the drug rapidly in 
the intestine after 5-6 hours of administration. So the above 
batches showed an increase in lag time from 3 to 6hrs with 
respect to their coating level. The batch TC5 (S2C2) shows the 
lag time of 5hrs which is required for time controlled drug 
delivery system. 
 
Dissolution study: In vitro dissolution studies of the different 
batches were carried out and depicted in the graphs. Ketoprofen 
release from batches TC1 to TC3 has been shown in Figure 
7.Ketoprofen release from tablet layered with 10 mg/cm2 of 
swelling layer and coated with ethylcellulose (2.5 mg/cm2) 
shows the lag time of 4 hours then follows the sigmoidal 
release pattern with 100% drug release at 10 th hour. As the 
concentration of the ethyl cellulose coating increases to (3.5 
mg/cm2) shows the lag time of 5hours then follows the 
Sigmoidal release pattern with 100% drug release at12 hour 
and ethyl cellulose (4.5 mg/cm2) also shows the lag time of 
8hour with 100% drug release at the 15 hour. Ketoprofen 
release from tablet layered with 20 mg/cm2 (TC4 to TC6 )of 
swelling layer and coated with ethylcellulose (2.5 mg/cm2) 
shows the lag time of 4 hours then follows the Sigmoidal 
release pattern with 100% drug release at 9 th hour. As the 
concentration of the ethyl cellulose coating increases from 20 
to 30 mg/cm2shows the lag time of 6 and 7 hour respectively 
and the further release profile shows delayed release after an 
initial lag time of 4 and 5 hour with the 100% drug release at 
the 10th and 12 th hour of as the coating level of ethyl cellulose 
increases up to 3.5 mg/cm2 and 4.5 mg/cm2 respectively. 
Ketoprofen release from tablet layered 20 mg/cm2 of swelling 
layer and coated with ethylcellulose (2.5 mg/cm2) shows with 
shows the lag time of 2 hours with 100% drug release at 6 th 
hour. As the concentration of the ethylcellulose coating 
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increases from 3.5 mg/cm2and 4.5 mg/cm2 shows delayed 
release after an initial lag time of 3 hour with the 100% drug 
release at the 8th hour.  
 
 
 
 Figure 7. Dissolution profile for batches TC1 to TC9 
To develop the time release tablet based on swelling and 
rupturable coatings, several studies were necessary to identify 
formulation variables, which provided the desired system 
properties, namely a rapid drug release after a certain lag time. 
The influence of core composition, level of swelling layer and 
rupturable coating, and magnesium stearate in rupturable layer 
was investigated. 
 
Effect of core composition: The effect of core composition on 
lag time of Time controlled release tablets of ketoprofen tablet 
shown in Figure 8. The amount of microcrystalline cellulose 
affects the lag time of the tablet. An increase in the 
concentration of microcrystalline cellulose causes the lag time 
to decrease. This decrease in lag time is totally independent on 
the coating level of Ac-Di-Sol and ethylcellulose. The decrease 
in lag time might be due to the higher disintegration property of 
microcrystalline cellulose which creates higher disintegration 
force and spray dried lactose which is highly soluble in water 
and has high osmotic activity. 
 
Figure 8. Effect of core composition on lag time of Time 
controlled release tablets     
Hence the core tablet prepared to use 70:30 w/w ratios of 
microcrystalline cellulose and Spray dried Lactose showed 
reproducible result and used as the optimized formulation to 
provide desired lag time which is essential for time controlled 
release tablet. 
 
Effect of swelling layer and rupturable coating on lag time: 
The effect of swelling layer and rupturable layer on lag time 
shown in Figure 9 and 10. In vitro dissolution studies of time 
controlled release tablets of Ketoprofen were carried out and it 
is found that the drug was not released prior to the rupturing of 
the coating. After rupturing, the drug release from the time 
controlled release tablets of Ketoprofen with 10.0 mg/ cm2 Ac-
Di-Sol layer were lower than that from the time controlled 
release tablets of Ketoprofen with 30 mg/cm2 Ac-Di-Sol layer. 
A swelling layer level of 10.0 mg/cm2 might not be enough for 
the complete rupture of the tablets (Flowlac 100: Avicel 
PH102, 70:30 w/w cores). As observed visually, tablets with 
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10.0 mg/cm2 Ac-Di-Sol layer showed a lower degree of 
rupturing than tablets with 30mg/cm2 Ac-Di-Sol layer. 
 
Figure 9. Effect of swelling layer on lag time of Time 
controlled release tablets of Ketoprofen   
 
The amount of swelling layer was an important variable 
influencing the rupturing. Unexpectedly, the lag time of tablets 
with a higher level of swelling layer increased at all ethyl 
cellulose coating levels. The hardness of the core tablets coated 
with croscarmellose sodium level 10mg/cm2, 20 mg/cm2, 30 
mg/cm2 was found to be high.  Core  tablets  coated  with  
higher  levels  of   croscarmellose sodium  (without  rupturable  
membrane)  had  a  higher hardness,  which  might  retard  the  
water  penetration  through  this layer. Croscarmellose sodium 
swelled when in contact with medium and therefore  probably 
retarded  the  further water penetration  into the core,  which  
by  itself  had  a  high  disintegration  force  resulting in short 
lag times.  Croscarmellose sodium layer was also more porous 
than the core, thus resulting in a lower swelling pressure. In 
case of pulsatile release tablets, both the tablet core and the 
swelling layer influenced the rupturing process. 
 
Figure 10. Effect of ethylcellulose coating level on lag time of 
Time controlled release tablets   
 
As expected, higher levels of the rupturable ethyl cellulose 
layer increased the lag time. The lag time increased with 
increasing ethylcellulose level, the drug was released rapidly 
and completely at ethylcellulose levels of 2.5 mg/cm2 and 3.5 
mg/cm2. At the higher ethylcellulose, level of 4.5 mg/cm2, the 
drug was released slower after the lag time; this was again 
caused by the lower degree of rupturing of the thicker coating. 
Effect of magnesium stearate in rupturable layer:  
 
Figure 11. Effect of magnesium stearate on lag time of time 
controlled release tablets Ketoprofen 
  
Time controlled release tablets of ketoprofen containing 
magnesium stearate in the rupturable coating decreased the lag 
time significantly compared to tablets without magnesium 
stearate and the slope of the curve was also less steep, 
indicating a more robust formulation. The addition of 
magnesium stearate to the ethylcellulose coating decreased the 
mechanical properties of film. This may be due to the reduced 
interaction between polymer chains caused by the presence of 
the hydrophobic solid particles. 
 
Scanning Electron Microscopy: The scanning of morphology 
of a cross-section area of the time controlled release tablet of 
Ketoprofen was carried out by using Scanning Electron 
Microscopy. The photograph shows the three parts of the tablet 
which are clearly visible, namely the dense tablet core, 
(microcrystalline cellulose, lactose and drug) (C), the more 
porous layer of the Ac-Di-Sol containing swelling layer (B), 
and the homogeneous ethylcellulose coating as the outer 
rupturable coating (A). 
 
 Figure 12. SEM photomicrograph of a cross-section of a 
pulsatile release tablet with a  swelling layer (20 mg/cm2) and a 
rupturable ethylcellulose coating (3.5 mg/cm2), magnification 
150_. (A) rupturable layer (B) swelling layer (C) core  
 
Rupture Test: The rupturing sequence of a time controlled 
release tablet of Ketoprofen was taken by Digital Camera. 
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Water influx and the subsequent volume expansion of the 
swelling agent caused the rupturing of the ethylcellulose 
coating. The drug was then released rapidly within a short 
period after a certain lag time due to the strong rupturing of the 
coating.  
 
 
 Figure 13. Rupturable sequence of time controlled tablets of 
Ketoprofen A to C- Water uptake studies, D- Rupture point, H- 
Total drug release 
 
Water uptake study: The water uptake study of time 
controlled release tablet of Ketoprofen Shows that higher ethyl 
cellulose levels retarded the water uptake. Interestingly, all 
curves showed an almost linear water uptake with time until 
critical water level, where the ethyl cellulose coating ruptured. 
The critical water uptake level was slightly higher at the higher 
level of ethyl cellulose.  
  
 
 
Figure 14. Effect of Ethylcellulose coating level on % water 
uptake of time controlled Release tablets with 10 mg/ cm2 Ac-
Di-Sol layer 
 
This could be explained by the higher mechanical strength of 
the thicker coating requiring a higher degree of swelling (water 
uptake) for rupturing. Water uptakes prior to rupture of the 
different batches were investigated as a function of the amount 
of rupturable ethylcellulose layer. 
 
Swelling index: The swelling index of time controlled release 
tablet of Ketoprofen was shown in Table 11. The swelling 
index of time controlled release tablet of Ketoprofen was 
higher at the lower level of ethylcellulose layer. As the coating 
level increased, the swelling index decreased. 
 
CONCLUSION 
The prepared time controlled release tablet satisfied the 
objective of the present research work to synchronize drug 
delivery to the circadian rhythms of rheumatoid arthritis. 
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Overlapping of drug release characteristic with the onset of 
pharmacological symptoms make the drug delivery system 
ideal for chronotherapy of rheumatoid arthritis, delay the 
release of drug and hence control the onset of drug action, 
minimize the frequency of drug administration by developing a 
once daily therapy administered at bedtime, improved therapy 
which exerts its action at a time when it is needed most and 
dose related side effects could be minimized, to achieve patient 
convenience and compliance. 
Table 11 Swelling Index of time controlled release ketoprofen tablet coated with different ethylcellulose levels 
Ethyl cellulose 
coating level 
(mg/cm2) 
Swelling index ± S.D. at  Time (hrs) 
1 2 3 4.30 5 5.30 6 6.30 
1.5 12.16 ± 0.01 14.81 ± 0.02 18.17 ± 0.02 22.68 ± 0.03 R    
2.5 8.51 ± 0.02 10.19 ± 0.01 13.88 ± 0.02 21.31 ± 0.02 24.43 ± 0.01 R   
3.5 3.85 ± 0.03 6.98 ± 0.03 9.91 ± 0.02 13.79 ± 0.02 18.37 ± 0.03 23.2± 0.03 R  
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